Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

TERT aberrancies: a screening tool for malignancy in follicular thyroid tumours

24 Apr 2018

Abstract excerpt

Telomerase reverse transcriptase ( TERT ) promoter mutations have been linked to adverse clinical parameters in thyroid cancer, but TERT -expressing tumours are not always mutated. Little is known regarding other TERT -related genetic aberrations. To delineate the role of TERT gene aberrancies in follicular thyroid tumours, 95 follicular carcinomas (FTCs), 43 follicular adenomas (FTAs) and 33 follicular tumours...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cancer-related Molecular Pathways
Share to Genetic factors in colorectal cancer
Share to Thyroid Cancer Diagnosis and Treatment

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 29692346
DOI: 10.1530/erc-18-0050

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

TERT aberrancies: a screening tool for malignancy in follicular thyroid tumoursPMID 29692346Read ↗

Clinical Routine TERT Promoter Mutational Screening of Follicular Thyroid Tumors of Uncertain Malignant Potential (FT-UMPs): A Useful Predictor of Metastatic DiseaseSemantic proximity Read ↗

TERT promoter mutational screening as a tool to predict malignant behaviour in follicular thyroid tumours-three examples from the clinical routine.Semantic proximity Read ↗

TERT promoter mutations in thyroid cancer.Semantic proximity Read ↗

Changes in the clinicopathological characteristics and genetic alterations of follicular thyroid cancer.Semantic proximity Read ↗

Preoperative Assessment of TERT Promoter Mutation on Thyroid Core Needle Biopsies Supports Diagnosis of Malignancy and Addresses Surgical Strategy.Semantic proximity Read ↗

TERT promoter mutations are a major indicator of poor outcome in differentiated thyroid carcinomas.Semantic proximity Read ↗

TERT promoter mutation as an early genetic event activating telomerase in follicular thyroid adenoma (FTA) and atypical FTA.Semantic proximity Read ↗

Frequent somatic TERT promoter mutations in thyroid cancer: higher prevalence in advanced forms of the disease.Semantic proximity Read ↗

Mutation profiles of follicular thyroid tumors by targeted sequencingSemantic proximity Read ↗

Pathological Diagnosis of Thyroid Nodules with Preoperatively Detected TERT Promoter Mutations in the Absence of BRAFV600E: A Bi-Center Series of 52 Cases.Semantic proximity Read ↗

Follicular thyroid cancer harboring TERT and TP53 mutations: A case report.Semantic proximity Read ↗

TERT Promoter Mutations in Thyroid Cancer.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.